JP2009541340A5 - - Google Patents

Download PDF

Info

Publication number
JP2009541340A5
JP2009541340A5 JP2009516666A JP2009516666A JP2009541340A5 JP 2009541340 A5 JP2009541340 A5 JP 2009541340A5 JP 2009516666 A JP2009516666 A JP 2009516666A JP 2009516666 A JP2009516666 A JP 2009516666A JP 2009541340 A5 JP2009541340 A5 JP 2009541340A5
Authority
JP
Japan
Prior art keywords
carbon atoms
compound according
compound
alkyl
prodrug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2009516666A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009541340A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/071515 external-priority patent/WO2007149829A2/en
Publication of JP2009541340A publication Critical patent/JP2009541340A/ja
Publication of JP2009541340A5 publication Critical patent/JP2009541340A5/ja
Ceased legal-status Critical Current

Links

JP2009516666A 2006-06-20 2007-06-19 治療用化合物 Ceased JP2009541340A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80528506P 2006-06-20 2006-06-20
PCT/US2007/071515 WO2007149829A2 (en) 2006-06-20 2007-06-19 Therapeutic compounds

Publications (2)

Publication Number Publication Date
JP2009541340A JP2009541340A (ja) 2009-11-26
JP2009541340A5 true JP2009541340A5 (enExample) 2010-08-05

Family

ID=38728727

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009516666A Ceased JP2009541340A (ja) 2006-06-20 2007-06-19 治療用化合物

Country Status (7)

Country Link
US (3) US7429669B2 (enExample)
EP (1) EP2046714B1 (enExample)
JP (1) JP2009541340A (enExample)
AU (1) AU2007261034B2 (enExample)
BR (1) BRPI0713587A2 (enExample)
CA (1) CA2657967A1 (enExample)
WO (1) WO2007149829A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE465986T1 (de) * 2005-01-14 2010-05-15 Allergan Inc Substituierte cyclopentane oder cyclopentanone zur behandlung von augenhochdruck
BRPI0713587A2 (pt) * 2006-06-20 2012-10-23 Allergan Inc descrição de compostos terapêuticos da invenção
AU2007272683B2 (en) * 2006-07-10 2012-08-23 Allergan, Inc. Substituted cyclopentane derivatives as therapeutic agents
AU2007272617B2 (en) * 2006-07-11 2012-11-01 Allergan, Inc. Cyclopentane derivatives as antiglaucoma agents
CA2675981A1 (en) * 2007-01-22 2008-07-31 Allergan, Inc. Thiophene derivatives useful as ocular hypotensive agents
ATE496903T1 (de) * 2007-02-01 2011-02-15 Allergan Inc Thiophenderivate als medikamente zur behandlung von okularer hypertonie
JP5453254B2 (ja) * 2007-07-03 2014-03-26 アラーガン インコーポレイテッド 眼圧降下用の治療用置換シクロペンタン類
US7662850B2 (en) * 2007-07-13 2010-02-16 Allergan, Inc. Therapeutic substituted chlorocyclopentanols
US7947732B2 (en) * 2007-07-13 2011-05-24 Allergan, Inc. Therapeutic substituted chlorocyclopentanols
WO2009111322A1 (en) * 2008-03-04 2009-09-11 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US8487091B2 (en) * 2008-03-04 2013-07-16 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US7964596B2 (en) 2008-03-07 2011-06-21 Allergan, Inc. Therapeutic compounds
EP2297085B1 (en) * 2008-04-24 2019-03-20 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
US7803798B2 (en) 2008-04-24 2010-09-28 Allergan, Inc. Therapeutic compounds
WO2009137411A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic compounds
US8592413B2 (en) * 2008-05-15 2013-11-26 Allergan, Inc. Therapeutic substituted cyclopentanes
AU2009249388B2 (en) * 2008-05-20 2014-04-03 Allergan, Inc. Therapeutic lactams
CA2724605A1 (en) * 2008-05-27 2009-12-03 Allergan, Inc. Prostaglandin prodrugs as hypotensive agents
DK2653468T3 (en) 2009-07-28 2016-06-06 Ono Pharmaceutical Co Bicyclic compound AND USE THEREOF FOR MEDICAL PURPOSES
WO2012102355A1 (ja) 2011-01-27 2012-08-02 小野薬品工業株式会社 二環式化合物およびその医薬用途
US9029574B2 (en) 2011-01-27 2015-05-12 Ono Pharmaceutical Co., Ltd. Bicyclic compound and use thereof for medical purposes
US9315486B2 (en) 2013-10-29 2016-04-19 Allergan, Inc. Therapeutic cyclopentanols, compositions thereof, and methods for use thereof
ES2693255T3 (es) * 2014-02-27 2018-12-10 Ono Pharmaceutical Co., Ltd. Compuesto que presenta actividad agonista de EP2 selectiva
ES2721525T3 (es) 2014-06-06 2019-08-01 Allergan Inc Novedosos agonistas de EP4 como compuestos terapéuticos
JP6773035B2 (ja) 2015-07-23 2020-10-21 小野薬品工業株式会社 Ep2アゴニスト活性を有する化合物
EP3480191B1 (en) 2016-06-30 2021-09-01 ONO Pharmaceutical Co., Ltd. Method for producing bicyclic compound

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980700A (en) 1971-10-07 1976-09-14 G. D. Searle & Co. Prostaglandin intermediates and optically active isomers thereof
ZA733967B (en) * 1972-06-15 1974-11-27 Erba Carlo Spa 9-desoxy-prosta-5,9(10),13-trienoic acid derivatives and process for their preparation
DE2256537A1 (de) 1972-11-17 1974-10-10 Merck Patent Gmbh Neue sulfide
US4073799A (en) 1975-02-27 1978-02-14 (Zaidanhojin) Sagami Chemical Research Center Process for producing 3-formylcyclopentanone derivatives
JPS51110557A (en) 1975-03-26 1976-09-30 Sagami Chem Res Rakutonsurufuidono seizohoho
US4094886A (en) 1976-03-01 1978-06-13 (Zaidanhojin) Sagami Chemical Research Center Process for producing allyl alcohol derivatives useful in prostaglandin synthesis
DE3543991A1 (de) * 1985-12-10 1987-06-11 Schering Ag Verfahren zur herstellung von 9(beta)-chlor-prostaglandinen
JP2943306B2 (ja) 1990-10-12 1999-08-30 住友化学工業株式会社 シクロペンタンアルデヒド類およびその製造法
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
DE69613693T2 (de) * 1995-05-18 2002-05-16 Allergan Sales, Inc. 2-heteroarylalkenylderivate der cyclopentano-heptan(heptaen)säure als therapeutisches mittel zur behandlung des erhöhten augeninnendruckes
US6531485B2 (en) 1997-06-23 2003-03-11 Pfizer Inc. Prostaglandin agonists
EP1108426A3 (en) 1999-12-02 2002-10-02 Pfizer Products Inc. Use of prostaglandin agonists to treat erectile dysfunction or impotence
JP4149153B2 (ja) 2001-09-28 2008-09-10 富士フイルム株式会社 ポジ型レジスト組成物
ATE465986T1 (de) * 2005-01-14 2010-05-15 Allergan Inc Substituierte cyclopentane oder cyclopentanone zur behandlung von augenhochdruck
US7323591B2 (en) * 2006-01-10 2008-01-29 Allergan, Inc. Substituted cyclopentanes or cyclopentanones as therapeutic agents
BRPI0713587A2 (pt) * 2006-06-20 2012-10-23 Allergan Inc descrição de compostos terapêuticos da invenção

Similar Documents

Publication Publication Date Title
JP2009543795A5 (enExample)
JP2009543792A5 (enExample)
JP2009543794A5 (enExample)
JP2009540009A5 (enExample)
JP2010500976A5 (enExample)
JP2010500416A5 (enExample)
JP2009535426A5 (enExample)
JP5702392B2 (ja) キサンチンオキシダーゼ阻害剤として効果的な新規化合物、その製造方法及びそれを含有する医薬組成物
WO2006098918B1 (en) Substituted gamma lactams as therapeutic agents
EP2382212B1 (en) Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
JP2010539152A5 (enExample)
JP2016515536A5 (enExample)
JP2014530900A5 (enExample)
JP2009519965A5 (enExample)
JPWO2012102255A1 (ja) インドール誘導体、またはその薬理学的に許容される塩
JP2009535307A5 (enExample)
JP2010504286A5 (enExample)
WO2013187496A1 (ja) 芳香族複素環化合物
RS57406B1 (sr) Derivat 4-alkinil imidazola i lekovi koji ga sadrže kao aktivni sastojak
JP2011500818A5 (enExample)
JP2010510232A5 (enExample)
WO2008008701B1 (en) Substituted cyclopentane derivatives as therapeutic agents
JP2010516778A5 (enExample)
WO2009055289A2 (en) Therapeutic substituted lactams
JP2009536967A5 (enExample)